Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by davgroon Oct 20, 2022 4:43pm
123 Views
Post# 35037470

RE:RE:Just a Friendly Reminder...

RE:RE:Just a Friendly Reminder...
nobeard wrote: Duster, Chinachin, stutters and stockings would be the ones with issues. Have been on ignore for quite awhile. I am not sure if they are all the same person or not, but they mostly verbally attack one person. I don't know what it takes for the moderators to put these posters in the penalty box.

Yeah, it is truly unfortunate that Mugsy has become the primary "troll magnet" on the ATE board but I am acquiring my own troll infestation as well.  I strongly believe in freedom of speech, so let the trolls bellow on.  I have chosen not to listen to them for they say nothing of relevant substance.

I have come to the conclusion that most of the trolls here are disgruntled ATE investors who have lost considerable capital on their investment and now need to lash out at management and longs for their misfortune.  What they fail to admit or own is that no one forced them to invest in ATE.  By investing in a biotech you are accepting an inherent risk along with huge potential reward hence the expression "no risk, no reward".

Then there are the penny flippers and swing or day traders.  That is tantamount to gambling.  In a bear market the odds are stacked against you especially if you are retail investor.  I can't recall ever seeing disgruntled gamblers trolling casino operators or online betting sites because they lost money gambling, so why stock forums.  If you choose to purchase a stock and in the long run you lose money, thats on you unless there was inherent fraud or regulatory violations on the part of the company.  The unknowns and risks with biotechs is huge, but if ATE gets approval for the next blockbuster pain medication so are the riches.  "Rome wasn't built in a day."

EOM
<< Previous
Bullboard Posts
Next >>